PharmGen Science Statistics

Total Valuation

KRX:004720 has a market cap or net worth of KRW 73.64 billion. The enterprise value is 74.17 billion.

Market Cap	73.64B
Enterprise Value	74.17B

Important Dates

The last earnings date was Thursday, March 20, 2025.

Earnings Date	Mar 20, 2025
Ex-Dividend Date	n/a

Share Statistics

KRX:004720 has 18.16 million shares outstanding. The number of shares has increased by 4.74% in one year.

Current Share Class	n/a
Shares Outstanding	18.16M
Shares Change (YoY)	+4.74%
Shares Change (QoQ)	+66.58%
Owned by Insiders (%)	11.94%
Owned by Institutions (%)	1.20%
Float	15.12M

Valuation Ratios

The trailing PE ratio is 26.63.

PE Ratio	26.63
Forward PE	n/a
PS Ratio	0.43
PB Ratio	0.30
P/TBV Ratio	0.30
P/FCF Ratio	50.24
P/OCF Ratio	30.88
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.17, with an EV/FCF ratio of 50.60.

EV / Earnings	26.57
EV / Sales	0.43
EV / EBITDA	7.17
EV / EBIT	12.99
EV / FCF	50.60

Financial Position

The company has a current ratio of 1.69, with a Debt / Equity ratio of 0.16.

Current Ratio	1.69
Quick Ratio	1.19
Debt / Equity	0.16
Debt / EBITDA	2.55
Debt / FCF	26.60
Interest Coverage	2.56

Financial Efficiency

Return on equity (ROE) is 1.16% and return on invested capital (ROIC) is 2.37%.

Return on Equity (ROE)	1.16%
Return on Assets (ROA)	1.88%
Return on Invested Capital (ROIC)	2.37%
Return on Capital Employed (ROCE)	3.57%
Revenue Per Employee	674.36M
Profits Per Employee	10.99M
Employee Count	254
Asset Turnover	0.49
Inventory Turnover	2.41

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -22.40% in the last 52 weeks. The beta is 0.63, so KRX:004720's price volatility has been lower than the market average.

Beta (5Y)	0.63
52-Week Price Change	-22.40%
50-Day Moving Average	4,162.30
200-Day Moving Average	4,691.28
Relative Strength Index (RSI)	54.08
Average Volume (20 Days)	71,293

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:004720 had revenue of KRW 171.29 billion and earned 2.79 billion in profits. Earnings per share was 152.25.

Revenue	171.29B
Gross Profit	107.87B
Operating Income	10.63B
Pretax Income	1.02B
Net Income	2.79B
EBITDA	15.26B
EBIT	10.63B
Earnings Per Share (EPS)	152.25

Full Income Statement

Balance Sheet

The company has 38.45 billion in cash and 38.99 billion in debt, giving a net cash position of -540.17 million or -29.75 per share.

Cash & Cash Equivalents	38.45B
Total Debt	38.99B
Net Cash	-540.17M
Net Cash Per Share	-29.75
Equity (Book Value)	249.43B
Book Value Per Share	13,736.10
Working Capital	45.29B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.38 billion and capital expenditures -918.70 million, giving a free cash flow of 1.47 billion.

Operating Cash Flow	2.38B
Capital Expenditures	-918.70M
Free Cash Flow	1.47B
FCF Per Share	80.71

Full Cash Flow Statement

Margins

Gross margin is 62.98%, with operating and profit margins of 6.20% and 1.63%.

Gross Margin	62.98%
Operating Margin	6.20%
Pretax Margin	0.59%
Profit Margin	1.63%
EBITDA Margin	8.91%
EBIT Margin	6.20%
FCF Margin	0.86%

Dividends & Yields

KRX:004720 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.74%
Shareholder Yield	-4.74%
Earnings Yield	3.79%
FCF Yield	1.99%

Stock Splits

The last stock split was on November 17, 2014. It was a reverse split with a ratio of 0.1.

Last Split Date	Nov 17, 2014
Split Type	Reverse
Split Ratio	0.1

Scores

KRX:004720 has an Altman Z-Score of 1.74. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.74
Piotroski F-Score	n/a